Human-on-a-Chip Safety Data for Tradipitant to be Presented at SOT 2026

|

Safety Evaluation of Tradipitant Dosing in 4-Organ Human-on-a-Chip System to be Presented at SOT 2026

A 4-organHuman-on-a-Chip® model was used to study the safety profile of tradipitant, the results supported its recent approval for motion sickness.

News Announcement
SOT Presentation Details

Presentation Details

Safety Evaluation of Supraphysiological Tradipitant Dosing under Differential Liver Metabolism

Presented by: Jessie Carlin, Ph.D., Vanda Pharmaceuticals

Monday, March 23, 2026, 4:15 PM PDT
Ballroom 6C

Details & Abstract

Learn more and discover how we can advance your pipeline faster and more efficiently

News Announcement
SOT Presentation Details

Explore Other Hesperos News

AD Paper - March 2026

Hesperos and UCF Researchers Publish Human-on-a-Chip® Study Revealing Peripheral Neuromuscular Pathology is not CNS Dependent in Alzheimer’s Disease

By Nate Post | 16 April 2026

Hesperos and UCF publish new study in Alzheimer’s and Dementia demonstrating peripheral neuromuscular pathology is NOT CNS dependent in Alzheimer’s Disease

AD Paper - March 2026 (1)

Human-on-a-Chip Safety Data for Tradipitant to be Presented at SOT 2026

By Hesperos | 23 March 2026

A 4-organHuman-on-a-Chip® model was used to study the safety profile of tradipitant, the results supported its recent approval for motion sickness.

Advanced Science - Malaria on on a Chip

Advanced Science Cover Page Features Hesperos’ Malaria-on-a-Chip Model

By Hesperos | 6 January 2026

Featured on the cover of Advanced Science, our study presents a human-derived Malaria-on-a-Chip system that captures the biology of infection and delivers actionable insights for real-world therapeutic translation.